Prolacta Bioscience names new director
23 November 2021 -

Prolacta Bioscience, a hospital provider of 100% human milk-based nutritional products for premature and critically ill infants, announced on Monday that it has named Dr Anne Beal as its new director.

Dr Beal is the founder and CEO of AbsoluteJOI Skincare. She is a clinically trained and board certified in paediatrics' and serves as the chief patient officer at a global biopharmaceutical company. She was the deputy executive director for the Patient Centered Outcomes Research Institute, and president of the Aetna Foundation. She has served as a medical researcher and faculty member at both Harvard Medical School and the Harvard School of Public Health.

Presently, Dr Beal serves as a nonexecutive director for GlaxoSmithKline and is a member of the Corporate Responsibility Committee that offers important oversight of the company's trust agenda, including policies on access to medicines, global health, inclusion and diversity, and environmental sustainability.

Dr Beal holds Bachelor of Arts in biology from Brown University and Master of Public Health from Columbia University's Mailman School of Public Health. She received her Doctor of Medicine from Joan and Sanford I Weill Medical College of Cornell University.